The 2 h time-frame of the experiments described here was chosen to allow specific PSGL1 mediated binding to tumor associated endothelia to be distinguished from EPR mediated passive accumulation in the tumor, the effects of which are usually assayed at 24 or 48 h (28). The gene discussed is SELPLG; the disease is neoplasm.